Operator: Good day, everyone, and welcome to today's Walgreen Company's Fourth Quarter 2010 Earnings Conference Call. As a reminder, today's call is being recorded.
At this time, for opening introductions, I would like to turn the call over to Mr. Rick Hans. Please go ahead, sir.
Rick J. Hans - Divisional VP of IR and Finance: Thank you, Brandon and good morning, everyone. Welcome to our fourth quarter and fiscal 2010 year-end conference call. Today, Greg Wasson, our President and CEO will discuss the quarter and fiscal year highlights and our continued progress in executing our core strategies. In addition, Wade Miquelon, Executive Vice President and Chief Financial Officer will detail our fourth quarter and fiscal year financial results. Also, joining us on the call and available for questions, is Kermit Crawford, our President of Pharmacy Services.
When we get to your questions, please limit yourself to one. As a reminder, today's presentation includes certain non-GAAP financial measures, and I would direct you to our website at investor.walgreens.com for the reconciliations. Also, I’m available throughout the day by phone to answer any additional questions you may have.
You can find a link to our webcast under our Investor Relations website. After the call, this presentation will be archived on our website for 12 months. We're also making the call available as a podcast. You can download that too at our Investor Relations website.
Certain statements and projections of future results made in this presentation constitute forward-looking information that is based on current market competitive and regulatory expectations that involve risk and uncertainty. Please see our latest Forms 10-K and 10-Q for a discussion of risk factors as they relate to forward-looking statements.
Now, I'll turn the call over to Greg.
Gregory D. Wasson - President and CEO: Thank you, Rick, and thank you, everyone, for joining us on our call this morning. Today, I want to cover three main points. First, our fourth quarter and year-end results; second, I'll discuss the initiatives we have underway to improve front end sales through our Customer Centric Retailing initiative; and finally, I'll highlight the industry leading efforts we are making to provide our customers with convenient access to flu immunizations as we continue to transform community pharmacy.
As you saw from our press release this morning, we reported record sales of $16.9 billion in the quarter, which is a 7.4% increase over last year. Fourth quarter net earnings per diluted share increased 11.4% to $0.49, which includes $0.05 per diluted share and acquisition and restructuring-related costs that compares with $0.44 in the same quarter a year ago and including $0.03 per diluted share in restructuring-related costs.
This quarter, we generated record cash flow from operations of $925 million, an increase of 8.6%. Net sales for fiscal year 2010 grew 6.4% to a record $67.4 billion, and net earnings per diluted share were up 5% to $2.12. Cash flow from operations in fiscal 2010 totaled $3.7 billion and free cash flow was a record $2.7 billion.